Insider Selling: Spectral Medical Inc. (TSE:EDT) Director Sells 150,000 Shares of Stock

Spectral Medical Inc. (TSE:EDT) Director Paul M. Walker sold 150,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of C$0.65, for a total value of C$97,500.00.

Paul M. Walker also recently made the following trade(s):

• On Tuesday, July 16th, Paul M. Walker sold 100,000 shares of Spectral Medical stock. The stock was sold at an average price of C$0.49, for a total transaction of C$49,000.00.

Spectral Medical Stock Performance

Shares of EDT opened at C$0.65 on Thursday. The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. Spectral Medical Inc. has a one year low of C$0.30 and a one year high of C$0.75. The company’s fifty day moving average price is C$0.60 and its 200 day moving average price is C$0.52. The company has a market capitalization of C$182.81 million, a PE ratio of -9.43 and a beta of 0.99.

Spectral Medical (TSE:EDT) last announced its earnings results on Friday, August 9th. The company reported C($0.02) earnings per share for the quarter. The company had revenue of C$0.47 million during the quarter. As a group, analysts expect that Spectral Medical Inc. will post -0.05 earnings per share for the current year.

Spectral Medical Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.